A panoramic aerial-style view of a sunlit Texas cattle ranch, broad green pastureland stretching toward a low horizon under a clear blue sky, with herds of beef cattle spaced naturally across the fields. In the midground, a modern, low-profile barn painted clean white features a discreet Biophage, Inc. logo near the entrance. Natural midday sunlight casts soft, short shadows, emphasizing the health and vitality of the animals and landscape. The photographic composition uses the rule of thirds, with the barn slightly off-center and the cattle distributed in gentle arcs, conveying scale and real-world application of bacteriophage therapies in livestock health. The mood is optimistic, grounded, and practical, reflecting sustainable agricultural biotechnology.

Animal Health

Transforming infectious disease management in horses and livestock through targeted phage therapeutics and disciplined regulatory execution.

Mission

Biophage, Inc. advances bacteriophage therapies that safeguard equine and livestock health, reduce antibiotic dependence, and align with rigorous EPA and FDA standards, uniting science, stewardship, and regulatory excellence to protect animals, producers, and global food security.

An advanced veterinary treatment bay designed for large animals, with a clean, rubberized floor and a sturdy, empty equine examination stall framed by brushed stainless-steel rails. On a nearby mobile cart, a sealed, clearly labeled “Bacteriophage Therapy – Equine Respiratory” infusion bag rests beside sterile tubing and a compact, digital infusion pump. Cool white ceiling lights provide bright, shadow-minimized illumination, reflecting gently off metal surfaces and emphasizing sterility and safety. The photographic composition is at eye level, using leading lines from the stall rails to draw attention toward the treatment cart. The mood is professional, reassuring, and highly clinical, illustrating how Biophage, Inc.’s therapies integrate seamlessly into modern veterinary practice without showing any animals or people.
A dramatic, ultra-detailed close-up of a stylized bacteriophage rendered as if photographed through a high-end electron microscope, with a geometric icosahedral head and slender tail fibers attaching to a textured, rod-shaped bacterium. The color palette is deep cyan and soft teal, with selective bright accents to differentiate viral and bacterial structures. A faint grid and data overlays hover in the blurred background, hinting at genomic analysis. Subtle studio-style lighting from one side creates crisp highlights along the viral capsid edges and gentle shadows on the bacterial surface. Shot in macro, with a shallow depth of field and photographic realism, the image feels precise, modern, and scientific, ideal for explaining phage mechanisms to investors.

Strategic Pillars for Phage Impact

Our R&D prioritizes clinically relevant phage cocktails, validated manufacturing processes, and robust stability data, while we map clear EPA and FDA milestones and collaborate with veterinarians, universities, and industry partners to accelerate responsible adoption across equine and food-animal markets.